Empagliflozin Tablet, a prominent member of Loncom Pharma's Antidiabetic Drugs, is a game-changer in diabetes management. This medication effectively regulates blood sugar levels, improving the quality of life for individuals with diabetes and reducing the risk of complications.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
